Sofinnova Investments, Inc. Eli Lilly & CO Transaction History

Sofinnova Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 15, 2024	BUY	$525.19 - $619.13 $33.9 Million - $39.9 Million	64,525 New	64,525 $37.6 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $33.9 Million - $39.9 Million	64,525 New	64,525 $37.6 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $42.6 Million - $50 Million	137,100 New	137,100 $47.1 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $13.5 Million - $15.4 Million	45,500 New	45,500 $14.7 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $32.6 Million - $42.2 Million	-180,501 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $23.6 Million - $30.5 Million	143,592 Added 389.04%	180,501 $33.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $13.8 Million - $18.2 Million	-105,523 Reduced 74.09%	36,909 $6.23 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $945,750 - $1.09 Million	-6,468 Reduced 4.34%	142,432 $21.1 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $20.3 Million - $24.4 Million	148,900 New	148,900 $24.4 Million

4,031

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $705B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.